Serum Institute of India insists ‘Covishield’ will be commercialised once trials are successful; read details
New Delhi: Serum Institute of India, has clarified that the current claims surrounding Covishield's availability in the media are completely false and conjectural. "Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use", SII said in a...











































